Moneycontrol PRO
HomeNewsBusinessStocksIpca Laboratories shares decline by 2.08% in today's session

Ipca Laboratories shares decline by 2.08% in today's session

With the stock's current price at Rs 1,386.30, Ipca Laboratories's performance is keenly observed by investors in the pharmaceutical sector.

June 03, 2025 / 10:59 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Ipca Laboratories's stock experienced a decline of 2.08% during today's trading session, with the price reaching Rs 1,386.30. This movement reflects a notable shift in investor sentiment.

    The decline places Ipca Laboratories among the losers in the NIFTY MIDCAP 150 index. The stock's performance is closely watched by investors, especially given its presence in this key mid-cap index.

    Financial Overview


    A review of Ipca Laboratories's financial performance provides additional context to its stock behavior. The following insights are derived from the company's consolidated financial statements.

    Quarterly Performance:

    PeriodRevenue (Cr)Net Profit (Cr)EPS
    Mar 20252,246.6965.782.67
    Dec 20242,245.37277.339.78
    Sep 20242,354.90245.449.05
    Jun 20242,092.63198.987.58
    Mar 20242,033.012.912.35
    Annual Performance:
    YearRevenue (Cr)Net Profit (Cr)EPSBVPSROE (%)Debt to Equity
    20247,705.04529.2125.82304.578.640.22
    20236,244.32491.9318.58233.168.060.25
    20225,829.79910.9534.85219.5116.090.14
    20215,419.991,148.8445.01371.7924.240.05
    20204,648.71611.3747.77288.1816.710.11

    Ipca Laboratories has demonstrated consistent revenue growth over the years. Revenue has increased from Rs 4,648.71 Cr in 2020 to Rs 7,705.04 Cr in 2024. However, net profit has fluctuated, with a recent figure of Rs 529.21 Cr in 2024.

    The latest quarterly results show a revenue of Rs 2,246.69 Cr for March 2025, with a net profit of Rs 65.78 Cr and EPS of Rs 2.67. Monitoring these trends is essential for understanding the stock's potential trajectory.

    The company’s performance ratios provide further insights. The debt-to-equity ratio has remained relatively stable, and various margin ratios reflect the company's profitability and efficiency. Ipca Laboratories’ financial health and market position will likely continue to influence its stock performance.

    With the stock's current price at Rs 1,386.30, Ipca Laboratories's performance is keenly observed by investors in the pharmaceutical sector.

    Alpha Desk
    first published: Jun 3, 2025 10:58 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347